CSE1L and cancer: In addition, developments in nanotechnology materials, safe viral delivery systems, and the synthesis of next-generation liposomes, polymers, nanoparticles, and peptides will increase the possibility of using the CRISPR-Cas system in cancer cells of patients [101].